A carregar...
Castration-resistant prostate cancer: latest evidence and therapeutic implications
Medical oncologists who treat men with castration-resistant prostate cancer (CRPC) have seen an abundance of new agents approved by the United States Food and Drug Administration in the last decade for a disease that was previously difficult to treat after becoming resistant to androgen-deprivation...
Na minha lista:
Main Authors: | , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
SAGE Publishing
2014-07-01
|
Colecção: | Therapeutic Advances in Medical Oncology |
Acesso em linha: | https://doi.org/10.1177/1758834014529176 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|